Blincyto (blinatumomab) Injection Side Effects & Price

 Blincyto (blinatumomab) is a prescription medication used to treat certain types of acute lymphoblastic leukemia (ALL). It is given as an intravenous infusion (injection into a vein) by a healthcare professional.


The recommended dosage of Blincyto depends on the patient's body weight and medical history. The starting dose is typically 9 mcg per day, which is gradually increased over the first few days of treatment to a maintenance dose of 28 mcg per day. The dosage may be adjusted based on the patient's response to the medication and any side effects.


Blincyto works by attaching to two proteins called CD19 and CD3, which are found on the surface of certain types of leukemia cells and immune cells. By attaching to CD19 and CD3, Blincyto helps to activate the immune system and destroy the cancer cells.


Common side effects of Blincyto include fever, chills, headache, nausea, fatigue, and infections. Blincyto can also cause serious side effects, such as cytokine release syndrome (a potentially life-threatening condition), neurologic toxicities, and infections. Patients should inform their healthcare provider immediately if they experience any of these symptoms or side effects.


It is important to discuss any potential risks and benefits of Blincyto with your healthcare provider before starting treatment. You should also inform your healthcare provider if you have a history of infections or other medical conditions, as well as any medications you are currently taking.

Comments

Popular posts from this blog

Tofacitinib Tablet 5 mg , Price & side Effects

Carfilzomib Injection 60 mg Price & Side Effects

Enhertu Injection 100 mg Price & Side Effects